An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
<p>Apolipoprotein A-I (apoA-I) mimetic peptides have been pursued as new therapeutic agents for the treatment of atherosclerosis, yet their precise mechanism responsible for atheroprotection remains unclear. Like apoA-I itself, most of these peptides are capable of stimulating cholesterol effl...
Main Author: | Xuelei Song, Paul Fischer, Xun Chen, Charlotte Burton, Jun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2009-01-01
|
Series: | International Journal of Biological Sciences |
Online Access: | http://www.biolsci.org/v05p0637.htm |
Similar Items
-
An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice
by: Shu-Chen Lu, et al.
Published: (2012-04-01) -
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I*
by: Brian J. Van Lenten, et al.
Published: (2008-11-01) -
Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01) -
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
by: Jonathan Dalla-Riva, et al.
Published: (2013-05-01) -
In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
by: Catherine C. Hedrick, et al.
Published: (2001-04-01)